Objective: To assess the carotenoid status in young type I diabetic patients and its relationship to the glycaemic control of the disease. Design: A follow-up study. Setting: Hospital Universitario Puerta de Hierro, Health Area VI of Madrid (Spain). Subjects: Forty-seven type I diabetic patients, followed for 2.5 years. Interventions: Coinciding with physical examination and laboratory tests, serum levels of carotenoids were analysed by HPLC, and dietary intake of carotenoids was evaluated by a semiquantitative food frequency questionnaire and 3-day prospective dietary records. Results: In type I diabetic patients, average intake, serum levels and correlations between diet and serum levels of carotenoids were comparable to those in reference non-diabetic groups. Between-subjects seasonal variations were observed for bcryptoxanthin intake and serum levels (higher in winter) and serum lycopene (higher in summer). Significant within-subjects seasonal changes were shown for dietary and serum b-cryptoxanthin and serum b-carotene. Serum carotenoids were unrelated to glycaemic control markers. Subjects with clinically acceptable glycaemic control showed lower lycopene intake than those with unacceptable control. Intake of carotenoids did not explain variance in insulin dose, fasting glycaemia, fructosamine or HbA 1c . With the exception of lycopene, serum carotenoids were predicted by dietary intake, but in no case by fasting glycaemia, HbA 1c or fructosamine. Conclusion: In type I diabetic patients, serum carotenoid concentrations and their variance are determined by dietary intake patterns, and are unrelated to the glycaemic control of the disease, as assessed by biochemical markers.
Introduction
Carotenoids constitute one of the major groups of phytochemicals in human diets. Apart from the provitamin A activity displayed by some of them, several other biological activities have been reported, including antioxidant capacity, blue light filtering, immune modulation and regulation of cell differentiation and proliferation (Bendich and Olson, 1989; Olson, 1993; Packer, 1993; Bertram and Bortkiewicz, 1995) . Epidemiological studies have shown that high carotenoid intake and/or serum concentrations are associated with lower risk for developing chronic and degenerative diseases (Ziegler, 1993; Bunce, 1994; Krinsky, 1994; Kohlmeier and Hastings, 1995; Steinmetz and Potter, 1996) .
It is widely assumed that serum concentrations of carotenoids reflect, at least to some extent, the consumption of carotenoid-containing foods, mainly fruit and vegetables, as well as the intake of food components (i.e. ascorbic acid, fibre) and thus, serum carotenoid status may be used as an index related to a healthy diet (Brevik et al., 2004) . However, both dietary intake and serum concentrations of carotenoids have shown a high variability both within and between subjects in different populations (Riboli et al., 1988; Ascherio et al., 1992; Scott et al., 1996; Olmedilla et al., 2001) . This fact reduces the reliability of assessing the status of carotenoids by using single determinations (Tangney et al., 1987) and may lead to an overestimation of the prevalence of high or low values when using fixed concentration ranges to classify subjects and/or risk assessment (Van den Berg et al., 1993; Olmedilla et al., 1994) .
In the management of diabetes, diet constitutes an essential component that should be integrated, along with insulin therapy and exercise, into the patient's lifestyle. Type I diabetes is a metabolic disorder in which the nutritional status of some micronutrients and related compounds may be altered. In fact, traditionally, type I diabetic patients have been classified as a group at risk for marginal nutritional status of some micronutrients (i.e. vitamin A, vitamin C, zinc) (Stepp et al., 1939; Mooradian et al., 1994; Basu and Basualdo, 1997) , as well as for a low antioxidant status or high oxidative stress (Wolff, 1993; Ndahimana et al., 1996; Dominguez et al., 1998; Dierckx et al., 2003) . Nevertheless, methodological issues may be related to these observations (Granado-Lorencio and Olmedilla-Alonso, 1999 ) since, in fact, similar or even higher circulating concentrations of several antioxidants (i.e. a-tocopherol, carotenoids) have been reported in these patients, even after adjusting for other potential confounding factors (i.e. sex, age, season, lipids) (Bates et al., 1997; Olmedilla et al., 1997; Granado et al., 1998) .
Based on this background, our aim was to evaluate the carotenoid status in type I diabetic patients by means of dietary methods and biochemical markers, and to study to what extent both carotenoid intake and serum concentrations are related to biochemical indexes of glycaemic control of the disease in these patients.
Subjects, material and methods

Description of patients
Between November 1993 and January 1997, sixty-nine subjects, clinically diagnosed with type I diabetes mellitus, were recruited among outpatients who regularly visited the Nutrition and Diabetes Section at Hospital Universitario Puerta de Hierro, Madrid, Spain. Subjects were selected from a larger group of diabetic patients scheduled to establish intensive insulin therapy (multiple daily blood glucose measurements and at least three insulin doses/day) within the context and objectives of the Diabetes Control and Complications Trial (DCCT) (Diabetes Control and Complications Trial Research Group, 1993) , basically the absence of disease symptoms and HbA 1c below 7.1%. In addition to clinical parameters, other inclusion criteria were: age between 14 and 35 years, duration of diabetes of less than 5 years, no spontaneous remission of the disease (during the time of the study), no apparent macrovascular or microvascular clinical complications, no intercurrent disease, no presence of hypertension or hypercholesterolemia, no use of vitamin, mineral or herbal supplements, no pregnancy and no use of oral contraceptives.
Subjects were included in the study at different time points coinciding with their visit to the hospital, and all patients were on 'conventional' insulin therapy (less than three injections/day) at the start of the study (baseline value) or had new-onset diabetes. According to these criteria, a total of 47 subjects (25 men, 22 women) were finally included in the study. Forty of these patients (19 men, 21 women) returned for at least two visits (at least 3-6 months of follow-up) with measurements that were all valid at each time point (see below). The duration of the study ranged between 3 and 30 months and the characteristics of the subjects at the start of the study are shown in Table 1 . Body mass index (BMI) and mean values (and CI 95% ) for the parameters shown in the table were within the accepted reference values except for fasting glucose, fructosamine and HbA 1c (%), which were characteristically above those established for non-diabetic subjects (Kratz et al., 2004) .
According to clinical criteria, patients visited the hospital every 3-6 months for evaluation. Coinciding with clinical examinations, blood samples were collected for biochemical, haematological and serum carotenoid analyses, and dietary intake of carotenoids was also recorded (see below). Although dietary assessment was focused on individual carotenoid intake, general information was obtained about all food groups and special dietary patterns (i.e. use of supplements, herbs and drugs). None of the subjects reported being on restricted, unusual or slimming diets, or having significantly changed their food habits during the study, with the exception of those changes because of the availability of seasonal foods. Biochemical markers (including indexes of glycaemic control, HbA 1c and fructosamine) and haematological profile were monitored throughout the study by means of analyses performed in the General Biochemistry and Haematology Laboratories of the hospital according to quality-controlled standardized methods. Microalbuminuria, BMI, frequency of episodes of hypoglycaemia, insulin units/day, multiple daily blood glucose measurements and the presence of infections were also monitored.
The study was approved by the Comité É tico de Investigació n Clínica of the Hospital Unversitario Puerta de Hierro. All subjects were informed and written consent was obtained from all of them or their caretakers.
Standards and reagents
Lycopene, lutein, a-and b-carotene and ammonium acetate were obtained from Sigma Chemical Co. (St Louis, MO, USA). Zeaxanthin and b-cryptoxanthin were generously supplied by Hoffmann-La Roche (Basel, Switzerland). Dichloromethane and tetrahydrofuran were purchased from Carlo Erba (Spain) and methanol, ethanol, hexane and acetonitrile were from Merck (Spain).
Assessment of dietary carotenoid intake
Coinciding with the visit to the hospital and blood sampling, carotenoid intake of the patients was assessed by means of two complementary dietary methods: a semiquantitative food frequency questionnaire (SFFQ) (retrospective) conducted by expert physicians and covering the 15 days preceding blood collection and 3-day records (prospectively within the week of blood collection). Both methods are considered to reflect habitual diet but display different sources of errors, and frequency of consumption explains most of the variability in carotenoid intake (Freudenheim et al., 1987; Garrow, 1995) .
Inclusion of fruits and vegetables in the questionnaire was based on nationwide data regarding food consumption statistics and food distribution networks, as well as food practices and eating habits. A total of 35 vegetables and 17 fruits, accounting for more than 97% of total fruit and vegetable consumption and carotenoid intake in our country were included as closed questions (individual consumption), in addition to open questions regarding other food items that could contribute significantly to carotenoid intake (i.e. loquat, mango). To assess individual carotenoid intake, we used food composition data generated by HPLC in Spanish foods, considering the total content of carotenoids (i.e. saponified values in fruits) . The quality of the data used (sampling, handling and analytical quality control) was assessed at Wageningen University and evaluated as 'highly acceptable' (3% top score) (Poorvliet and West, 1993) .
Carotenoid analysis in serum
Fasting venous blood samples from all volunteers were collected in plain blood tubes containing no anticoagulant.
Serum was separated by centrifugation (630 g, 10 min) and stored at À201C until analysis (within 6 months). Sample extraction and HPLC analysis was carried out as described elsewhere (Olmedilla et al., 1997) . Briefly, 0.5 ml of serum was mixed with 0.5 ml of ethanol containing internal standard (retinyl acetate), vortexed and extracted twice with 2 ml of methylene chloride/hexane (1:5). Organic phases were pooled, evaporated to dryness and reconstituted to be injected onto the HPLC. The chromatographic system consisted of a Spheri-5-ODS column (Applied Biosystems, San José, CA, USA) with gradient elution of acetonitrile/ methanol (85/15) for 5 min to acetonitrile/methylene chloride/methanol (70/20/10) for 20 min. Ammonium acetate (0.025 M) was added to the methanol. Detection was carried out by photodiode array detector (Model 996, Waters Associates, Milford, USA) set at 450 nm for carotenoids.
When applicable, all the samples from a given patient corresponding to consecutive visits (i.e. baseline, 3 and 6 months) were analysed on the same day to reduce analytical variability. The short-and long-term precision and accuracy of the analytical method were contrasted periodically through our participation in the Fat-Soluble Quality Assurance Programme conducted by the National Institute of Standards and Technology (NIST; Gaithersburg, MD, USA).
Statistical analysis
Descriptive statistics (mean, standard deviation, median, range and quartiles) were calculated for all variables. Since dietary intake and serum carotenoids did not meet the criteria for normal distribution (Kolmogorov-Smirnov Z test), sex, seasonality and effect of glycaemic control, using clinical cutoff points (HbA 1c p7.1%), were analysed with non-parametric tests (Mann-Whitney U and Wilcoxon T tests). Biochemical indexes of glycaemic control (fructosamine and HbA 1c ) were compared using one-way ANOVA and post hoc Scheffé test. The differences in the dietary intake of carotenoids according to the two methods used were calculated with Spearman's coefficients and partial correlation coefficients (controlling for season) and Bland-Altman plots. Within-subject changes in BMI, insulin dose and biochemical indexes of glycaemic control during the followup study were evaluated by repeated measures analyses using the general linear model. To assess within-subject seasonal variation in dietary intake and serum levels of carotenoids, and to maintain statitical power, seasons were pooled (winter-autum vs spring-summer) on the basis of the differences observed in the one-way ANOVA analysis and the differences in the lifestyle and dietary patterns. Only one observation from each pooled season (consecutive, within the year) was used for each participant and differences were assessed by paired t test and Wilcoxon signed rank test. Relationships between dietary intake and serum concentrations of carotenoids, glycaemic control indexes and insulin dose were assessed by Spearman correlation coefficients and linear regression analysis (including correlated variables in univariate analysis, dietary intake of individual carotenoid and physiologically relevant variables). Statistical significance was set at Po0.05 and analysis was performed with SPSS 8.0 for Windows statistical software (SPSS Inc., Chicago. IL, USA).
Results
During the follow-up study (up to 2.5 years), a total of 254 visits were registered and 236 SFFQs and 176 3-day records were collected. When this information was reviewed, a number of cases were excluded owing to a lack of compliance and inconsistencies in the diaries, leaving a total of 145 reliable cases with the three measurements (SFFQ, 3-day records and serum carotenoid and biochemical analyses) at each time point for statistical analysis.
Average dietary intake and serum concentrations of individual carotenoids throughout the study are shown in Table 2 . Compared to 3-day records, FFQs produced higher values of intake for all the carotenoids except b-cryptoxanthin, reaching statistical significance for lutein, zeaxanthin, a-carotene and b-carotene. Similarly, significant differences for the same carotenoids were observed at entrance (n ¼ 40). Bland-Altman plots for each carotenoid showed concordance between the two dietary methods (using statistical limits; i.e. 2 s.d.) in 480% of the cases (data not shown). Correlation was observed between the two dietary methods of assessment and between these methods and serum concentrations in terms of dietary intake of carotenoids, although higher coefficients were obtained using SFFQ (Table 3 ). In addition, considering serum concentrations of carotenoids as the reference ('gold standard'), the rate of misclassification of subjects in opposite quartiles was lower (on average o5%) with the SFFQ than with 3-day records. Thus, on the basis of these results and the better correlation with serum concentrations using SFFQ, dietary intake of carotenoids as assessed by the SFFQ was used for subsequent analysis.
Throughout the study, women displayed higher average serum concentrations of lutein, a-carotene and b-carotene compared to men, reflecting the differences observed in dietary intake (using SFFQ), and differences between sexes were also found for insulin dose (higher in men, Po0.01) and HDL (higher in women, Po0.05). Both dietary methods revealed seasonal changes in intake for some carotenoids, although these differences were only statistically significant for b-cryptoxanthin (Po0.001, using SFFQ), with a higher consumption in winter compared with the rest of the year (Figure 1) . Similarly, average serum concentrations of major carotenoids also showed seasonal variations but only those in b-cryptoxanthin (higher in winter) and lycopene (higher in summer) reached statistical significance (Po0.001 and Po0.05, respectively) (Figure 2 ). Significant within-subject variations were observed for b-cryptoxanthin in serum and diet (higher in autum-winter) as well as for b-carotene in serum (higher in spring-summer) (Table 4) .
Except for the markers of metabolic control of the disease (fasting glycemia, HbA 1c and fructosamine), both at baseline and throughout the study, average values for BMI and biochemical indexes were within the reference values. At the group level, only a trend towards lower average values for HbA 1c and fructosamine was observed, and although Correlations between intake and serum concentrations of carotenoids and biochemical indexes at the start of the study are shown in Table 5 . As shown, serum concentrations of carotenoids were unrelated to indexes of glycaemic control and only insulin dose was inversely associated with both dietary intake and serum levels of a-carotene and positively associated with dietary intake of lycopene. In addition, since HbA 1c provides an insight into the glycaemic control over the preceding 3 months (time gap), we also studied the potential relationships of serum and dietary carotenoids quantified at a certain time point to HbA 1c values obtained 3 months later (HbA 1c (3 þ )) , but, again, no significant correlations were observed (Table 5) .
In linear regression models (at entrance, n ¼ 40), dietary intakes of carotenoids did not enter as predictors of fasting glycaemia, fructosamine or HbA 1c (and HbA 1c (3 þ )). Except for lycopene, dietary intake of carotenoids explained between 26 and 38% of serum carotenoid concentration variance (up to 62% for b-cryptoxanthin). In no case did fasting glycaemia, HbA 1c (or HbA 1c (3 þ )), fructosamine or insulin dose enter in the models as predictors of serum concentrations of carotenoids in these patients.
Discussion
Carotenoid status in type I diabetic patients In the present study, the analytical quality control, the multiple evaluations of the subjects and the complementary methods used to assess the carotenoid status that comprise different sources of errors (i.e. recall errors, dietary changes, serum concentrations) support the reliability of the carotenoid status observed in this group of patients, even when the distribution of carotenoids in a population may be influenced by analytical uncertainties, sampling bias and differences in the distribution of the analytes among populations (Sharpless and Duewer, 1995) .
On a quantitative basis, type I diabetic patients showed mean intakes of major carotenoids higher than those reported in the Spanish general population . Consistent with this observation, serum concentrations of carotenoids in type I diabetic patients were above the median reference values reported in Spanish controls (Olmedilla et al., 1997 Granado et al., 1998) Table 2 . Carotenoids status and type I diabetes F Granado-Lorencio et al they fell within the intervals reported for other European non-diabetic reference groups . In addition, both between-and within subjects, seasonal variations in dietary intake and serum concentrations of some carotenoids (i.e. lycopene, b-cryptoxanthin) were significant in the present study, as previously reported in our country (Olmedilla et al., 1994; Granado et al., 1996) . Studies in different populations have shown that serum concentrations of carotenoids reflect, at least qualitatively, short-term dietary intake (Riboli et al., 1988; Ascherio et al., 1992; Olmedilla et al., 1994 Olmedilla et al., , 2001 Scott et al., 1996; Burri et al., 2001; Granado et al., 2004) . However, owing to their highly variable bioavailability, serum carotenoids cannot be considered as direct exposure markers. In fact, correlations observed between dietary intake and serum concentrations of carotenoids vary widely, from total absence to values of 0.6, depending on the carotenoid, dietary method used, group assessed and even season of the year (Yong et al., 1994; Jarvinen, 1996; Scott et al., 1996; Dierckx et al., 2003) . In this context, our results show that carotenoid diet-serum correlations in type I diabetic patients are similar to or higher than those observed in non-diabetic populations (Yong et al., 1994; Jarvinen, 1996; Scott et al., 1996; Dierckx et al., 2003) , a finding that was consistent between the different methods used in the present study.
With regard to diet-serum relationships, compared to other carotenoids, serum levels of b-cryptoxanthin were higher in relation to its dietary intake. Unreliable data on dietary intake of b-cryptoxanthin derived from incomplete questionnaires and/or underestimation of b-criptoxanthin content in food databases seem unlikely since, in our population, major contributors of b-cryptoxanthin (oranges, tangerines, red peppers) are identified both annually and seasonally, and all were included in the SFFQ. Also, because of the low number of relevant contributors to b-cryptoxanthin intake, estimated absolute intake may be more reliable than, for example, for b-carotene which is determined by many items and, thus, is more apt to be overestimated. In addition, since data used on the bcryptoxanthin content in foods came from our qualityassessed analysis (Poorvliet and West, 1993; Olmedilla et al., 1996) , which refers to total content in foods (after ester hydrolysis), underestimation of this value is unlikely. Supporting these arguments is the fact that b-cryptoxanthin intake, as assessed by SFFQ, explained up to 62% of bcryptoxanthin in serum, the highest proportion when compared to all the other carotenoids and two-fold greater than that explained using 3-day records (ca. 28%, data not shown).
This strong relationship may be, partly, related to a higher bioavailability compared to other carotenoids. b-Cryptoxanthin is mostly provided by fruits containing ester forms, which have been suggested to be more stable under digestion conditions. Interestingly, in humans, b-cryptoxanthin-rich fruits have been reported to be more efficient in raising retinol serum levels than green vegetables, suggesting a higher bioavailability of provitamin A carotenoids from fruits (De Pee et al., 1998) . In addition, similar to what was observed in control subjects, about two-thirds of the bcarotene absorbed is effectively converted into retinol in type I diabetics (Goodman et al., 1966; Van Vliet et al., 1995; Granado et al., 2001) . Thus, a potential overestimation of b-carotene intake along with a relatively higher bioavailability of b-cryptoxanthin (and the half provitamin A value) may explain, at least in part, the higher serum level despite a lower intake of b-cryptoxanthin, compared to that of b-carotene.
A second point concerns the consistently nonsignificant and relatively low correlation between serum concentration and dietary intake of lycopene. Even though the coefficients obtained are comparable to those previously reported (Yong et al., 1994; Scott et al., 1996; Jarvinen, 1996) , we found no statistical significance regardless of the method used. Methodological inaccuracies (i.e. SFFQ design, number of participants) may account for this fact. As in the case of b-cryptoxanthin, major dietary contributors to lycopene intake are relatively few (i.e. tomato products, watermelon) and, again, all were also included in the SFFQ. However, although we focussed on carotenoid intake from fresh/raw fruits and vegetables and we specifically included questions regarding consumption of tomato products (i.e. paste, ketchup), we failed to collect information on the consumption of mixed and/or composite meals containing tomato (i.e. pizza). In addition, the bioavailability of lycopene from raw tomatoes has been reported to be much lower that that from processed tomato (Stahl and Sies, 1992) and thus, the underestimation of lycopene content in meals containing processed tomato products, along with the lower bioavailability of this carotenoid from fresh sources, may have contributed to the relatively low correlation observed. Overall, these results indicate that the serum carotenoid status and its variability in these patients are comparable to those reported in non-diabetic groups and are mostly determined by the dietary patterns. In addition, our observations support a relevant within-subject variability in carotenoid status in type I diabetic patients and, as pointed out in non-diabetic subjects, this variance reduces the reliability for classifying subjects and assessing relative risks in these patients if single measurements are used (Tangney et al., 1987; Van den Berg et al., 1993; Olmedilla et al., 1994) .
Carotenoid status and glycaemic control
In the present study, the indexes of glycaemic control (fructosamine, HbA 1c ) in patients under intensive insulin therapy were not significantly altered, a fact that may be related to the inclusion of young subjects with new-onset diabetes and patients with moderately acceptable glycaemic control at the start of the study. At entrance and throughout the study period, no significant correlations were found between serum carotenoid status and parameters of glycaemic control, coinciding with the lack of association observed between serum b-carotene and HbA 1c or markers of oxidative stress (Dominguez et al., 1998; Vessby et al., 2002; Dierckx et al., 2003) .
In this regard, we found a significant inverse association between insulin dose and serum and dietary a-carotene and a positive association with lycopene intake. However, although intake of all carotenoids apparently explained about one-third of the insulin dose variance using linear regression models (data not shown), none of them individually reached statistical significance and most were removed from the model on including other variables (i.e. fasting glycemia, BMI). Nevertheless, since carotenoid intake may be considered a marker of fruit and vegetable consumption, the potential relationship between dietary carotenoid intake and insulin dose is not surprising, since a balanced, plant-rich diet, along with insulin therapy and exercise, constitute the three pillars of diabetes management. Interestingly, the positive association between lycopene intake and insulin dose and the lower lycopene intake in subjects showing a better metabolic control (HbA 1c o7.1%) is somehow inconsistent with this viewpoint and, regardless of the lack of correlation between serum levels and dietary intake, the potential role of lycopene in relation to glucose metabolism and, more likely, as a marker of certain food habits or food components (i.e. carbohydrate-rich, high glycaemic index foods) in these subjects deserves attention.
Apparently, results from the present study do not support a consistent or relevant relationship between carotenoid status and glucose metabolism. However, serum carotenoids may be considered markers of a healthy diet (i.e. fruit and vegetable-rich, high fibre, low glycaemic index carbohydrates), reflecting recent dietary intake both in type I diabetic patients and non-diabetic subjects (Granado et al., 2004) , whereas HbA 1c and fructosamine provide insights into longer-term disease control. That is, serum carotenoids and glycaemic parameters are markers not only of different processes, but on a different time scale as well. Thus, the lack of significant associations between dietary intake or serum levels of carotenoids and clinically relevant markers of metabolic control (i.e., HbA 1c ) should not be surprising.
Hyperglycaemia results in an increased production of free radicals, impaired glucose metabolism and insulin action, and contributes to long-term diabetic complications (Wolff, 1993; Giugliano et al., 1996; Ceriello, 2003) . In this respect, different studies, based on single determinations, have reported a higher oxidative stress in these patients, in whom serum b-carotene was lower than in controls (Dominguez et al., 1998; Vessby et al., 2002; Martín-Galán et al., 2003) . However, interpretation of these data should be done with caution since, in these studies, dietary intake was not assessed and, thus, the 'true' exposure to the nutrient was, in fact, unknown. In addition, owing to the highly variable bioavailability and simultaneous presence of phytochemicals in foods (collinearity), the low concentration of a single compound in serum, that is, b-carotene, does not necessarily indicate a marginal status of other biologically active substances, that is, vitamin C, lycopene or b-cryptoxanthin, as reported in non-diabetic groups (Olmedilla et al., 1997 , especially considering the synergistic actions of many of them.
Finally, our results support the hypothesis that in type I diabetic patients, serum carotenoid concentrations and their variance are mostly determined by dietary intake patterns, and that carotenoid status in serum is unrelated to clinical markers of glycaemic control within the ranges observed in this study. Although a potential role of serum carotenoids in type I diabetes cannot be ruled out, given that they reflect short-term dietary intake and may vary widely, both within and between subjects, single determinations of carotenoids in serum may be of little relevance with respect to their relationship to long-term diabetic complications.
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